Peter Wolf

This study investigates the metabolic effects of eIF1A and eIF3B inhibition in psoriasis models, finding context-dependent metabolic changes and therapeutic benefits.

The paper inhibits eIF1A and eIF3B in psoriasis models, reducing inflammation and restoring skin health in mice and human 3D models.

The paper identifies Nitrosocosmicus species as commensals in the human skin microbiome through cultivation and genomic analysis, showing their adaptation to skin environments.

This study shows that activating GP130 in prostate epithelial cells suppresses tumor growth through senescence and immune activation, suggesting a new therapeutic approach.